Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
The take-home message: doctors' views on letters and tapes after a cancer consultationM Stockler, P N Butow, M H Tattersall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of responseI Tannock, M Gospodarowicz, W Meakin, et al.
Cancer Treatment Reviews|May 18, 2000
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancerM Stockler, N R Wilcken, D Ghersi, et al.
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|December 5, 2018
Successful surgical resolution of a ceco-cecal intussusception in a 15-month-old Angus heiferGustavo Ferlini Agne, Ricardo M Stockler, Thomas Passler, et al.
Journal of Dairy Science|August 25, 2009
Effect of milking frequency and dosing interval on the pharmacokinetics of cephapirin after intramammary infusion in lactating dairy cowsR M Stockler, D E Morin, R K Lantz, et al.
Progress in Clinical and Biological Research|January 1, 1986
Experimental models of bladder cancer: a critical reviewD Raghavan, F Debruyne, H Herr, et al.
The Journal of Sports Medicine and Physical Fitness|June 1, 1989
Potassium content of the fat free body in childrenL Cordain, J E Johnson, C N Bainbridge, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 21, 2009
Effect of milk fraction on concentrations of cephapirin and desacetylcephapirin in bovine milk after intramammary infusion of cephapirin sodiumR M Stockler, D E Morin, R K Lantz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Resource implications of palliative chemotherapy for ovarian cancerC Doyle, M Stockler, M Pintilie, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2010
A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research GroupM M Moore, M Stockler, R Lim, et al.
Pageof 7